Mobile medical applications’ state quo and underlying barriers: review of literature†
Article Category: Review
Pubblicato online: 09 ott 2022
Pagine: 241 - 246
Ricevuto: 08 apr 2022
Accettato: 17 mag 2022
DOI: https://doi.org/10.2478/fon-2022-0029
Parole chiave
© 2022 Ting-Ting Zhou et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Objective
To explore the current development and challenges regarding mobile medical applications (mmAPPs), so as to provide reference for application function elevation and quality improvement.
Methods
We retrieved literature databases like Web of Science, PubMed, China National Knowledge Infrastructure, Wanfang, China Biomedical Network, time limit was from January 1, 2010 to December 31, 2021, and restricted to the Chinese or English language.
Results
This study concluded with the following six aspects: Domestic and foreign development of mmAPP, reminder function, barriers and challenges (low quality; slow update rate; lack of standard evaluation tool or criterion), privacy and safety concerns, adverse drug event report state (low report rate-related reasons, different countries’ report policies), and current hindrances in the progression (economic worries; personal education level; acceptance and study of technology; rural districts, and low-income countries).
Conclusions
We should focus on the application's quality elevation rather than quantity, pay more attention to patients’ adverse drug event reports, privacy and safety, and place emphasis on rural districts and low-income countries.